ATE107360T1 - Expression von menschlichen apolipoproteinen ai- milano in hefe. - Google Patents

Expression von menschlichen apolipoproteinen ai- milano in hefe.

Info

Publication number
ATE107360T1
ATE107360T1 AT90906181T AT90906181T ATE107360T1 AT E107360 T1 ATE107360 T1 AT E107360T1 AT 90906181 T AT90906181 T AT 90906181T AT 90906181 T AT90906181 T AT 90906181T AT E107360 T1 ATE107360 T1 AT E107360T1
Authority
AT
Austria
Prior art keywords
yeast
milano
expression
human apolipoproteins
apolipoprotein
Prior art date
Application number
AT90906181T
Other languages
English (en)
Inventor
Alessandro Sidoli
Francisco Baralle
Cesare Sirtori
Guido Franceschini
Original Assignee
Cesare Sirtori
Guido Franceschini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cesare Sirtori, Guido Franceschini filed Critical Cesare Sirtori
Application granted granted Critical
Publication of ATE107360T1 publication Critical patent/ATE107360T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90906181T 1989-04-20 1990-04-17 Expression von menschlichen apolipoproteinen ai- milano in hefe. ATE107360T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920226A IT1229996B (it) 1989-04-20 1989-04-20 Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.

Publications (1)

Publication Number Publication Date
ATE107360T1 true ATE107360T1 (de) 1994-07-15

Family

ID=11164927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906181T ATE107360T1 (de) 1989-04-20 1990-04-17 Expression von menschlichen apolipoproteinen ai- milano in hefe.

Country Status (10)

Country Link
EP (1) EP0469017B1 (de)
JP (3) JP3082941B2 (de)
AT (1) ATE107360T1 (de)
AU (1) AU641389B2 (de)
CA (1) CA2053288C (de)
DE (1) DE69010000T2 (de)
DK (1) DK0469017T3 (de)
ES (1) ES2054353T3 (de)
IT (1) IT1229996B (de)
WO (1) WO1990012879A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9103701D0 (sv) * 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
FR2686605B1 (fr) * 1992-01-27 1994-03-11 Rhone Poulenc Rorer Sa Nouveaux polypeptides, leur preparation et leur utilisation.
SE9203753D0 (sv) * 1992-12-11 1992-12-11 Kabi Pharmacia Ab Expression system for producing apolipoprotein ai-m
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
DK0954524T3 (da) * 1996-09-11 2003-08-04 Pharmacia Ab Fremgangsmåde til rensning af apolipoproteiner
JP2000513945A (ja) * 1996-09-11 2000-10-24 エスペリオン セラピューティクス インコーポレイテッド プロセスにおける使用のためにアポリポタンパク質および組成物を精製するためのプロセス
SE9603304D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
BR0115257A (pt) * 2000-11-10 2003-08-12 Proteopharma Aps Análogos de apolipoproteìna
PL372925A1 (en) 2001-09-28 2005-08-08 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
WO2005051413A2 (en) * 2003-11-26 2005-06-09 Novartis Ag Disease associated genes
JP2007531537A (ja) 2004-04-06 2007-11-08 セダーズ−シナイ　メディカル　センター アポリポタンパク質ａ−ｉおよびアポリポタンパク質ａ−ｉｍｉｌａｎｏをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置
KR100560102B1 (ko) 2004-06-25 2006-03-13 한국생명공학연구원 프로아포리포단백질 ａ－ⅰ 변이체와, 이를 포함하는고지혈증 또는 동맥경화증 예방 및 치료제
CN1320119C (zh) * 2004-12-09 2007-06-06 复旦大学 人载脂蛋白ApoAⅠ在毕赤氏酵母胞内表达的方法
US7759315B2 (en) 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
EP2465519B1 (de) 2007-03-01 2013-10-23 CSL Limited Behandlung von endothelialer Dysfunktion bei Diabetes-Patienten
US10894098B2 (en) 2012-04-09 2021-01-19 Signablok, Inc. Methods and compositions for targeted imaging
US20130137628A1 (en) 2010-05-11 2013-05-30 Esperion Therapeutics, Inc. Dimeric Oxidation-Resistant Apolipoprotein A1 Variants
US20130310304A1 (en) * 2010-06-15 2013-11-21 Matthew C. Lawyer Compositions and methods for the treatment of atherosclerosis
FR2961814B1 (fr) * 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
EP0239631A4 (de) * 1985-10-04 1989-01-12 Biotech Res Partners Ltd Rekombinante apolipoproteine und verfahren.
GB8625435D0 (en) * 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader

Also Published As

Publication number Publication date
JP3082941B2 (ja) 2000-09-04
IT1229996B (it) 1991-09-20
JPH05504673A (ja) 1993-07-22
JP3845101B2 (ja) 2006-11-15
JP2004339229A (ja) 2004-12-02
AU5424590A (en) 1990-11-16
JP2000212098A (ja) 2000-08-02
CA2053288C (en) 2006-06-06
AU641389B2 (en) 1993-09-23
DK0469017T3 (da) 1994-10-03
DE69010000T2 (de) 1994-09-22
IT8920226A0 (it) 1989-04-20
EP0469017A1 (de) 1992-02-05
DE69010000D1 (de) 1994-07-21
ES2054353T3 (es) 1994-08-01
EP0469017B1 (de) 1994-06-15
WO1990012879A3 (en) 1991-05-16
WO1990012879A2 (en) 1990-11-01
CA2053288A1 (en) 1990-10-21

Similar Documents

Publication Publication Date Title
ATE107360T1 (de) Expression von menschlichen apolipoproteinen ai- milano in hefe.
GR3003819T3 (de)
CA2080462A1 (en) Therapeutic uses of actin-binding compounds
DK221589A (da) Fremgangsmaade til at udtrykke ikke-gaerprotein i en gaervaert og transformeret gaervaert
AU4403689A (en) Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
ATE91714T1 (de) Transformation von trichoderma.
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
GB2302329A (en) Yeast strains
HU9200548D0 (en) Improved activity process of recombined proteins
AU3330384A (en) Human Y interferon fragment and production from recombinant microbes
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
ZA894721B (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria,and gene therefor
AU2157888A (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2023560A1 (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
ATE81136T1 (de) Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung.
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
KR890700661A (ko) 효모에 의한 플라즈모듐 팔시파룸의 외주포자소체 단백질의 발현
NO925048D0 (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
GR3005736T3 (de)
AU3328289A (en) Expression of hepatitis B2 pres protein in methylothrophic yeasts
ATE154608T1 (de) Verwendung einer mischung von peptiden and aminosäuren für die prophylaxis oder behandlung von dementia
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
IT1226796B (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IL89993A0 (en) Expression of the hiv 24kda gag protein in methylotrophic yeasts
NO891485D0 (no) Fremgangsmaate til fremstilling av 22 kd-sgh-protein og lineaer genevektor.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee